CDMO News
Conduit Pharmaceuticals Partners with Agility Life Sciences for Autoimmune Pipeline Development
Conduit Pharmaceuticals Inc. has entered into a strategic services agreement with Agility Life Sciences, a formulation development contract development and manufacturing organisation (CDMO). The partnership focuses on developing new oral-dosage formulations for Conduit’s autoimmune pipeline, leveraging Agility’s expertise to support
23 January 2025